leisure time -WSS

leisure time

author：comprehensive 2025-09-30 22:27:30 - browse：6833

portrait of Jennifer Adair -- coverage from STAT — Jennifer Adair develops scalable, low cost gene therapies at the Fred Hutchinson Cancer Center and helped found the Global Gene Therapy Initiative. Fred Hutch News Service

BALTIMORE — Gene and cell therapies have transformed a handful of devastating disorders in the U.S. and Europe, with more treatments on the way. But those technologies have largely failed to reach most of the world.

These lags are ubiquitous in the current drug development system, where new therapies are approved in wealthy countries and then slowly leak out to low- and middle-income countries, many years later. In the case of gene therapy, that means countries most affected by a disease such as sickle cell may wait decades to access a curative therapy.

For the last few years, a handful of researchers in the U.S. and around the world have tried to find ways of ensuring global access to these technologies. In 2020, they formed the Global Gene Therapy Initiative, with an initial goal of setting up a gene therapy clinical trial for a hemoglobinopathy — such as a disease like sickle cell or beta thalassemia — or HIV in two different low- and middle-income countries by 2024.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： H5N1 bird flu outbreak: Second human case reported, in Michigan

WSS

Some medical students still think black patients feel less pain

Should insurance cover cosmetic surgery?

Addressing health care workers' trauma can help fight burnout

At flashy new research hub, AstraZeneca lays out ambitious growth goals

Guardant Health colon cancer test endorsed by FDA advisory panel

Scrutiny of post

hotspot

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

focus

Medicare proposal to cover medical devices draws a mixed reaction

Addressing health care workers' trauma can help fight burnout

Hepatitis C has a cure — but many Americans still lack access to it

Scrutiny of post

After affirmative action ruling, medical educators look to 'holistic review'

Questions and answers about ramping up H5N1 bird flu vaccine

New air purifier tech could be key to improving indoor air quality

Readout Newsletter: H5N1 bird flu vaccine, Cytokinetics, Gilead

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

The HPV vaccine prevents cancer in men, too. Why do so few people get it?

hotspot

Liver decline slowed by off

Study finds gene variants tied to breast cancer risk in Black women

ASCO eve: Let’s set the table for this year's meeting

Stroke rates rising, especially in working

Protect nursing home residents from future pandemics

Decentralized clinical trials need collaboration to achieve wider use

hotspot

entertainment

leisure time

focus